An observational study in Glaucoma, sponsored by Manchester University NHS Foundation Trust. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2023-08-01.
Sponsored by Manchester University NHS Foundation Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Glaucoma with a site in United Kingdom — 4 open to participants now, 5 under way, none of them phase 3. Glaucoma · United Kingdom.
Among the 48 studies in Glaucoma with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 20 observational ones that give a count, is one of 2 that started in 2023, is one of 20 observational ones, and was the 45th registered.
1,421 studies on the registry are indexed under Glaucoma; 221 are open to participants now.
Browse Glaucoma studies →4 of the 48 studies in Glaucoma with a site in United Kingdom are open now. Recruiting first, the newest first:
Buckinghamshire Healthcare NHS Trust · Sites in United Kingdom
Ages 18–99
iSTAR Medical · Sites in United Kingdom, Honduras
Ages 20+
Association for Innovation and Biomedical Research on Light and Image · Sites in United Kingdom, Germany, Italy and 2 more countries
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 154 Glaucoma studies recruiting now, 112 (73%) set no upper age limit and 9 (6%) stop at 75 or younger; 13 take children under 18; 44 take healthy volunteers.
This study: 18 Years to 110 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 2 · Phase 3 7 · Phase 4 6
First in 1999; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 101 across 386 observational studies indexed under Glaucoma.
Median enrollment 90 across the 28 interventional studies, 100 across the 20 observational. Of the 37 that completed or were terminated, 14 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 48 have an industry lead sponsor. The 10 most frequent:
Manchester University NHS Foundation Trust is the lead sponsor of 140 studies on the registry; 27 are open to participants now.
Manchester University NHS Foundation Trust has 2 studies filed under Glaucoma — fewer than ten, so there is no comparison to draw.
2 of the studies in Glaucoma with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07009236iSTAR MedicalA Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma | 2026-12 |
| NCT05024695iSTAR MedicalEvaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 48 studies in Glaucoma with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Glaucoma can affect both central and peripheral vision. Clinicians need to discuss with patients the vision related driving standards and any specific limitations their patients may have relating to their ability to drive with glaucoma. According to the recent guidelines by the General Optical Council (GOC), clinicians are advised to make sure that the Driving and Vehicle Licensing Agency (DVLA) is informed about patients who do not meet the driving vision standards. There are several limitations in making a professional judgement about a patient's suitability to drive and in providing appropriate advice to patients. The main concern is discussing this sensitive issue with the patient based upon available clinical evidence e.g. vision or visual field and directing them to inform the DVLA of their condition or potentially advising them to stop driving. The purpose of this research is to investigate the two main issues 1. To explore patients' understanding of standards of vision for driving. 2. Comparing the standards of vision for driving estimated in the clinic with number plate vision. We propose to do a mixed methods analysis using a patient survey and quantitative investigation of driving vision standards.
The two main objectives that we propose to study in this project are
Patients attending glaucoma clinics.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Inclusion Criteria for Quantitative vision estimation:
Exclusion criteria for Patient survey:
Exclusion Criteria for Quantitative vision estimation:
Questionnaire to understand patients driving needs and understanding of driving vision standards
DVLA vision standard estimated in the clinic is compared with standandard car number plate outside the clinic. We estimate the vision in the clinic using standard visual acuity chart and electronic number plate vision and compare with number plate vision estimated outside the clinic by the patient. Instruction to estimate number plate vision will be provided to the patient.
Other: Driving assessment in glaucoma patient
One group of patient will be given questionnaire while the other group will respond to a questionnaire while the other group will have vision assessment. Patients could participate in both groups.
Also known as: 1. questionnaire to patient. 2.Assessment of vision using visual acuity chart and number plate vision
Ability to read 6/12 or above in vision chart with both eyes.
Binocular Vision assessment in Logmar testing
Time frame: 6 months
Vision Chart score in each eye
Unilateral Vision testing Logmar testing
Time frame: 6 months
Ability to read the number plate in the clinic displayed in the VDU
Ability to read the number plate in the clinic displayed in the VDU comparative visual display unit
Time frame: 6 months
Ability to read the car number plate outside the clinic
Ability to read the car number plate outside the clinic as per patients self assessment
Time frame: 6 months
Start is estimated for Aug 2023; primary completion for Oct 2023, 2 months later.
Of 111 non-industry observational studies under Glaucoma, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 208. This study's planned 2 months is below that.
Counting every sponsor, half of 135 studies reached it within 31 months; a quarter within 11 and three quarters within 208.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Manchester University NHS Foundation Trust →